| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.5 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.11 | 0.5 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.03 | 0.5 |